WN1316

TargetMol
Product Code: TAR-T35135
Supplier: TargetMol
CodeSizePrice
TAR-T35135-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35135-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T35135-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
WN1316 is a unique neuroprotectant against oxidative injury, being a highly promising remedy for the treatment of amyotrophic lateral sclerosis (ALS).
CAS:
1356959-71-1
Formula:
C20H26Cl3N5O
Molecular Weight:
458.81
Purity:
0.98
SMILES:
Cl.Cl.Cl.CN(CC(=O)Nc1nc(c[nH]1)-c1ccccn1)c1c(C)cc(C)cc1C

References

Kanno T, Yasutake K, Tanaka K, Hadano S, Ikeda JE. A novel function of N-linked glycoproteins, alpha-2-HS-glycoprotein and hemopexin: Implications for small molecule compound-mediated neuroprotection. PLoS One. 2017 Oct 9;12(10):e0186227. doi: 10.1371/journal.pone.0186227. eCollection 2017. PubMed PMID: 29016670; PubMed Central PMCID: PMC5633190. Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Inoue S, Hirayama N, Ikeda JE. A novel acylaminoimidazole derivative, WN1316, alleviates disease progression via suppression of glial inflammation in ALS mouse model. PLoS One. 2014 Jan 31;9(1):e87728. doi: 10.1371/journal.pone.0087728. eCollection 2014. PubMed PMID: 24498180; PubMed Central PMCID: PMC3909264.